Genomes and Genes
Summary: Schedule giving optimum times usually for primary and/or secondary immunization.
Publications255 found, 100 shown here
- Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey dataAndrew Clark
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
Lancet 373:1543-9. 2009..We estimated vaccination coverage at different ages, and delays in administration, in 45 low-income and middle-income countries...
- Epidemiology of pertussisTina Tan
Feinberg School of Medicine, Division of Infectious Disease, Children s Memorial Hospital, 2300 Children s Plaza, Box 20, Chicago, IL 60614 3394, USA
Pediatr Infect Dis J 24:S10-8. 2005..Understanding the link between these observations may lead to better informed global control strategies, especially those pertaining to immunization schedules and use of pertussis vaccine...
- A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescentsEric E Mast
Division of Viral Hepatitis, National Center for Infectious Diseases, USA
MMWR Recomm Rep 54:1-31. 2005..The second part of the ACIP statement, which will include updated recommendations and strategies to increase hepatitis B vaccination of adults, will be published separately...
- Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United StatesHayley A Gans
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 5208, USA
J Infect Dis 190:83-90. 2004..Shifts in peak measles incidence to children <12 months old and the associated high mortality support the study of an early 2-dose measles vaccine regimen...
- Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai childrenArunee Sabchareon
Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Pediatr Infect Dis J 23:99-109. 2004..The safety and immunogenicity of tetravalent live-attenuated dengue vaccines after a three dose vaccination series were evaluated in Thai children...
- Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdomRay Borrow
PHLS Meningococcal Reference Unit, Withington Hospital, Manchester, United Kingdom
Infect Immun 71:5549-55. 2003..This study provides the first evidence that the number of doses of MCC-TT used in infant immunization schedules could be decreased...
- Hepatitis B and the need for a booster doseElke Leuridan
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Edegem, Belgium
Clin Infect Dis 53:68-75. 2011..However, a booster dose should be planned for immunocompromised patients, based on serological monitoring...
- A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adultsEric E Mast
Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
MMWR Recomm Rep 55:1-33; quiz CE1-4. 2006....
- Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adultsSorachai Nitayaphan
Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
J Infect Dis 190:702-6. 2004..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
- Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayedElizabeth T Luman
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 293:1204-11. 2005..Only 18% of children in the United States receive all vaccinations at the recommended times or acceptably early...
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts
Medical Research Council Laboratories, Banjul, The Gambia
Lancet 365:1139-46. 2005..Pneumonia is estimated to cause 2 million deaths every year in children. Streptococcus pneumoniae is the most important cause of severe pneumonia. We aimed to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children...
- Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairsPeter Aaby
Bandim Health Project, Apartado 861, Bissau, Guinea Bissau
Int J Epidemiol 33:367-73. 2004..As background information, we examined sex- and age-specific mortality patterns in the pre-vaccination era. Subjects In all, 626 female-male twin pairs identified between 1978 and 2000...
- Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluationPhilippe De Wals
Faculty of Medicine, Laval University, and Quebec National Institute of Public Health, Canada
Vaccine 24:3500-4. 2006..Results showed that the efficacy of any immunization schedule was highly influenced by the rate at which immunity waned and that the benefit of a booster dose increased ..
- Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional studyJuliet N Babirye
School of Public Health, Makerere University College of Health Sciences, Kampala Uganda
PLoS ONE 7:e35432. 2012..In addition to examining timeliness of the recommended Expanded Programme for Immunisation (EPI) vaccines, this paper identifies predictors of untimely vaccination among children aged 10 to 23 months in Kampala...
- Alternative vaccination schedule preferences among parents of young childrenAmanda F Dempsey
Child Health Evaluation and Research Unit, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109 5456, USA
Pediatrics 128:848-56. 2011..We sought to describe national patterns of alternative vaccination schedule use and the potential "malleability" of parents' current vaccination schedule choices...
- Immunogenicity of a three-component acellular pertussis vaccine administered at birthCesare Belloni
Division of Neonatology and Neonatal Intensive Care, IRCCS Policlinico San Matteo Pavia, Italy
Pediatrics 111:1042-5. 2003..Furthermore, we investigated the influence of maternal antibodies on aP vaccine response...
- Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in GermanyDorothee M Kieninger
Arztin für Kinder und Jugendmedizin, Zentrum für Kinder und Jugendmedizin der Universitätsmedizin der Johannes Gutenberg Universität Mainz KOR, Mainz, Germany
Vaccine 28:4192-203. 2010..Vaccines were comparable with regard to safety. PCV13 should be as effective as PCV7 in preventing pneumococcal disease caused by the common serotypes and may provide protection against the additional serotypes...
- Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countriesSean P Fitzwater
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Hum Vaccin 6:810-8. 2010..Here, we present a synthesis of data supporting various Hib vaccine schedules, with a focus on the implications for developing countries...
- Vaccination coverage and timeliness in three South African areas: a prospective studyLars T Fadnes
Centre for International Health, University of Bergen, Norway
BMC Public Health 11:404. 2011..Timely vaccination is important to induce adequate protective immunity. We measured vaccination timeliness and vaccination coverage in three geographical areas in South Africa...
- Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancyF M Russell
Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children s Hospital, Melbourne, Australia
Vaccine 28:3086-94. 2010..By 17 months the PPV-23 group still had significantly higher GMC (each p<0.001) for all serotypes. The PPV-23 was well tolerated and induced excellent responses for all serotypes which were greatest in the single PCV-7 group...
- Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from UgandaLars T Fadnes
Centre for International Health, University of Bergen, 5018 Bergen, Norway
Vaccine 29:3564-70. 2011..Timely vaccination is important to protect children from common infectious diseases. We assessed vaccination timeliness and vaccination coverage as well as coverage of vitamin A supplementation in a Ugandan setting...
- The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization scheduleMartin O Ota
Medical Research Council Laboratories, Banjul, Gambia
Vaccine 29:2999-3007. 2011....
- Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaignElena Chiappini
Department of Sciences for Woman and Child s Health, University of Florence, Viale Pieraccini, Florence, Italy
Acta Paediatr 99:1609-14. 2010..In the absence of randomized controlled trials that support a specific schedule, each country has adopted different vaccination programmes. Hereby, we analyse positive and negative aspects of the different vaccination strategies...
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximabSander Van Assen
Department of Internal Medicine, Division of Infectious Diseases, University Medical Center Groningen, Groningen, The Netherlands
Arthritis Rheum 62:75-81. 2010..We also undertook to assess the safety of influenza vaccination and the effects of previous influenza vaccination...
- General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)William L Atkinson
Immunization Services Division, National Center for Infectious Diseases, USA
MMWR Recomm Rep 51:1-35. 2002..This report, ACIP recommendations for each vaccine, and other information regarding immunization can be accessed at CDCs National Immunization Program website at http.//www.cdc.gov/nip (accessed October 11, 2001)...
- Effectiveness of individually tailored calendars in promoting childhood immunization in urban public health centersMatthew W Kreuter
Health Communication Research Laboratory, Division of Behavioral Science and Health Education, Department of Community Health, School of Public Health, Saint Louis University, St Louis, MO 63104, USA
Am J Public Health 94:122-7. 2004..We examined the effectiveness of tailored calendars in increasing childhood immunization rates...
- Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trialTerry Nolan
Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
JAMA 303:37-46. 2010..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children...
- Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trialRoly D Gosling
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
Lancet 374:1521-32. 2009..However, rising resistance to this combination is a concern. We investigated a shortacting and longacting antimalarial drug as alternative regimens for IPTi...
- Addressing immunization barriers, benefits, and risksSanford R Kimmel
Department of Family Medicine, University of Toledo College of Medicine, Toledo, OH, USA
J Fam Pract 56:S61-9. 2007..They must also clearly communicate vaccine benefits and risks while understanding those factors that affect an individual's acceptance and perception of those benefits and risks...
- Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New GuineaDeborah Lehmann
Papua New Guinea Institute of Medical Research, Goroka and Tari, Papua New Guinea
Int J Epidemiol 34:138-48. 2005..This study aimed to determine the effects of diphtheria-tetanus-whole-cell-pertussis (DTP), BCG, hepatitis B, and measles vaccines on mortality in the highlands of Papua New Guinea (PNG)...
- Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck
WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
Pediatr Infect Dis J 27:861-9. 2008....
- Immunisation coverage in Australian Indigenous children: Time to move the goal postsKerry Ann O'Grady
School of Population Health and Department of Paediatrics, University of Melbourne, Victoria, Australia
Vaccine 27:307-12. 2009..5% and 81.2% at 13 and 18 months of age, respectively. Immunisation performance benchmarks must focus on improving the timeliness in these children in the first year of life...
- Immunization status of children admitted to a tertiary-care hospital of north India: reasons for partial immunization or non-immunizationDevendra Kumar
Department of Pediatrics, University College of Medical Science and Guru Teg Bahadur Hospital, Delhi 110 095, India
J Health Popul Nutr 28:300-4. 2010..The immunization status needs to be improved by education, increasing awareness, and counselling of parents and caregivers regarding immunizations and associated misconceptions as observed in the study...
- Systematic review of the effects of pertussis vaccines in childrenTom Jefferson
Health Reviews Ltd, Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy
Vaccine 21:2003-14. 2003..To assess the efficacy and safety of whole-cell and acellular pertussis vaccines administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines...
- Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategiesL Coudeville
Sanofi Pasteur, Lyon, France
Epidemiol Infect 136:604-20. 2008..The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis...
- Scheduling of measles vaccination in low-income countries: projections of a dynamic modelC T Bauch
Department of Mathematics and Statistics, University of Guelph, Guelph, ON N1G 2W1, Canada
Vaccine 27:4090-8. 2009..If RI remains stagnant, India and Nigeria should hold SIAs every 2 years, and the other countries every 4-6 years...
- Infant pertussis: who was the source?Kristine M Bisgard
Bacterial Vaccine Preventable Diseases Branch, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 23:985-9. 2004..In the United States in the 1990s, the incidence of reported pertussis in adults, adolescents and infants increased; infants younger than 1 year of age had the highest reported incidence...
- Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune responseMaría Victoria Lavigne
Instituto de Estudios de la Inmunidad Humoral CONICET UBA, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junín 956 Piso 4, 1113 Buenos Aires, Argentina
Microbes Infect 6:481-4. 2004..is not necessary for protection against tetanus and therefore should be avoided, an alternative DTP immunization schedule with minimal Pw exposure was assessed in order to obtain a Th2 tetanus response and a Th1 pertussis ..
- Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis BGillian M Keating
Adis International Limited, Auckland, New Zealand
Drugs 63:1021-51. 2003..In addition, it appears that Hep-B(Eng) confers immunity for at least 10 years. Hep-B(Eng) has an important role in mass vaccination campaigns against hepatitis B, as well as in groups considered at high risk of acquiring hepatitis B...
- Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoproteinSuzanne L Epstein
Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Bethesda, MD 20852, USA
Vaccine 23:5404-10. 2005..Thus, gene-based vaccination with NP may contribute to protective immunity against diverse influenza viruses through its ability to stimulate cellular immunity...
- Early Impact of the US Tdap vaccination program on pertussis trendsTami H Skoff
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop C 25, Atlanta, GA 30333, USA
Arch Pediatr Adolesc Med 166:344-9. 2012..To evaluate the impact of the adolescent Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) vaccination program on pertussis trends in the United States...
- Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?Neil Z Miller
Think Twice Global Vaccine Institute, USA corrected
Hum Exp Toxicol 30:1420-8. 2011..The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year--the most in the world--yet 33 nations have ..
- Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controllMenno R van den Bergh
Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
Pediatr Infect Dis J 30:e170-8. 2011..Recent reviews have highlighted the unpredictability of immunologic interference when multivalent conjugated vaccines are coadministered with other pediatric vaccines...
- Long-term protection against hepatitis B after newborn vaccination: 20-year follow-upL Roznovsky
Department of Infectious Diseases, University Hospital Ostrava, Tr 17 listopadu 1790, 708 52 Ostrava, Czech Republic
Infection 38:395-400. 2010..However, whether this protection against carriage of hepatitis B virus is maintained into early adulthood is as yet unknown...
- Protecting infants against measles in England and Wales: a reviewG Manikkavasagan
HPA Centre for Infections, London NW9 5EQ, UK
Arch Dis Child 94:681-5. 2009..To establish the most appropriate age ranges for the use of human normal immunoglobulin and MMR vaccine as postexposure prophylaxis...
- Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in ArgentinaG Fabricius
Instituto de Investigaciones Fisicoquimicas Teoricas y Aplicadas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
Epidemiol Infect 141:718-34. 2013..An effort to improve the coverage of the first dose would have a much greater impact on infants. These results hold in the 18 scenarios considered, which demonstrates the robustness of these conclusions...
- Effectiveness of measles vaccination and vitamin A treatmentChristopher R Sudfeld
Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD 21205, USA
Int J Epidemiol 39:i48-55. 2010....
- Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian populationLawrence H Moulton
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Trop Med Int Health 10:947-55. 2005..The aim of this study was to assess the relationship between receipt of routine childhood immunizations and infant mortality before 6 months of age...
- Accelerating control of pertussis in England and WalesHelen Campbell
Health Protection Agency, London, UK
Emerg Infect Dis 18:38-47. 2012..e., <3 months of age), teenagers, and adults. Future vaccine program changes may be beneficial, but additional detail is required to inform such decisions...
- The impact of computer-generated messages on childhood immunization coverageE F Dini
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Am J Prev Med 18:132-9. 2000..This study assesses the sustained impact of computer-generated messages on immunization coverage during the first two years of life...
- Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old childrenM E Pichichero
Department of Microbiology, University of Rochester School of Medicine, Rochester, New York, USA
Pediatrics 105:e11. 2000....
- Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambsC de la Rosa
Department of Animal Science, Cornell University, Ithaca, NY 14853 4801, USA
J Anim Sci 75:2328-34. 1997..Because concentrations of .2 IU/mL may be protective, these results indicate that vaccination of ewes before lambing imparts passive protection in lambs to 12 wk of age, whereas vaccination of young lambs provides no added protection...
- Effectiveness and net cost of reminder/recall for adolescent immunizationsChristina A Suh
Children s Outcomes Research Program, Children s Hospital Colorado, Aurora, Colorado 80045, USA
Pediatrics 129:e1437-45. 2012..To assess the effectiveness of reminder/recall (R/R) for immunizing adolescents in private pediatric practices and to describe the associated costs and revenues...
- Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the NetherlandsTjalke A Westra
Department of Pharmacy, University of Groningen, The Netherlands
Clin Ther 32:1479-95. 2010..Because pertussis is most severe in unimmunized infants and infants who have only received some of the recommended doses, new pertussis immunization strategies should be considered to protect this vulnerable population...
- Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn
Center for HIV AIDS, Constella Futures, Washington, DC, USA
J Acquir Immune Defic Syndr 46:222-30. 2007..vCP1452 was administered alone or with a heterologous boost of MN rgp120 glycoprotein. The trial was pivotal in deciding whether these vaccines advanced to phase 3 efficacy trials...
- DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-BissauPeter Aaby
Projecto de Saude de Bandim, Apartado 861, Bissau, Guinea Bissau
Vaccine 25:1265-9. 2007..The sequence is not always respected. We examined in-hospital mortality of children having received DTP with or after measles vaccine...
- Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and VifMai Yoshikawa
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
J Biosci Bioeng 111:597-9. 2011..Here we show that the immunization schedule affects the immune phage antibody library properties. We subcutaneously (s.c...
- Hepatitis B Vaccine in national immunization schedule: a preventive step in IndiaRAMESH VERMA
Department of Community Medicine, Pt B D Sharma PGIMS, Rohtak Haryana, India
Hum Vaccin 7:1387-8. 2011..The current immunization schedule for hepatitis B vaccine includes a dose given as early as possible after birth, preferably within 24 hours ..
- Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccinationVeronica Kolos
University of Sydney, Australia
Vaccine 25:588-90. 2007..These data suggest that residence in a remote area, as a proxy for poorer living conditions for indigenous people, and delayed vaccination, both contribute to higher pertussis hospitalization rates in indigenous infants...
- The relation of parent and provider characteristics to vaccination status of children in private practices and managed care organizations in MarylandN Hughart
Department of Maternal and Child Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205, USA
Med Care 37:44-55. 1999..This study sought to identify provider practices and policies in private pediatric settings that relate to vaccination status, controlling for the characteristics of the children served...
- Minimum time interval adjustment for 4-3-1 immunization rates among two-year-old childrenR P Steiner
Department of Family and Community Medicine, University of Louisville, Kentucky 40292, USA
Am J Prev Med 16:189-94. 1999....
- Predictors of age-appropriate receipt of DTaP dose 4Tara W Strine
Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Am J Prev Med 25:45-9. 2003In the United States, the national childhood immunization schedule calls for children to receive four doses of DTaP (diphtheria and tetanus toxoids and acellular pertussis) vaccine administered at 2, 4, 6, and 15 to 18 months...
- Compliance with national immunization guidelines for children younger than 2 years, 1996-1999Loren K Mell
Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
Pediatrics 115:461-7. 2005..To evaluate compliance with national immunization guidelines among a large cohort of children cared for at health maintenance organizations (HMOs) and to examine effects on immunization status...
- Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in NicaraguaManish Patel
Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
JAMA 301:2243-51. 2009..Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country...
- Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization scheduleM Magdalena Gherardi
Department of Molecular and Cellular Biology, Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, Campus Universidad Autonoma, Madrid, Spain
J Immunol 172:6209-20. 2004..Our findings are of relevance in the area of vaccine development and support the optimization of protocols of immunization based on MVA as vaccine vectors to induce mucosal immune responses against HIV...
- Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humansJ J Treanor
Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
Vaccine 19:1732-7. 2001..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
- Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United StatesIsmael R Ortega-Sanchez
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 46:1-13. 2008..The objective of our study was to analyze the cost-effectiveness of a catch-up vaccination campaign with quadrivalent meningococcal conjugate vaccine for children and adolescents aged 11-17 years...
- When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone agesElizabeth T Luman
National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia 30333, USA
Am J Prev Med 36:105-11. 2009....
- A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birthSalvacion Gatchalian
Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
Hum Vaccin 1:198-203. 2005..A birth dose of HBV is important to maximize protection against hepatitis B in endemic regions where the EPI schedule is in place...
- General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)Andrew T Kroger
Immunization Services Division, National Center for Immunization and Respiratory Diseases proposed, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 55:1-48. 2006..cdc.gov/nip...
- Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple dosesArunee Sabchareon
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Am J Trop Med Hyg 66:264-72. 2002..All subjects seroconverted to serotype 3 after one dose. Serotype 4 elicited the lowest primary response but the highest increase in seroconversion after the second dose...
- Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experienceS Salmaso
Laboratories of Epidemiology and Biostatistics and Bacteriology and Medical Mycology, Istituto Superiore di Sanita, Rome, Italy
Pediatrics 108:E81. 2001..Therefore, the objective of this study was to estimate the persistence of protection from 3 to 6 years of age of the 2 3-component DTaP vaccines administered as primary immunization in infancy...
- Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysisFangjun Zhou
National Immunization Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia 30333, USA
Pediatrics 110:653-61. 2002..To evaluate the economic impact of universal Haemophilus influenzae type b (Hib) vaccination starting at 2 months of age...
- Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of ageLennart Gustafsson
Swedish Institute for Infectious Disease Control, SE 171 82 Solna, Sweden
Pediatrics 118:978-84. 2006..The purpose of this work was to evaluate the long-term effectiveness of vaccination with acellular pertussis vaccines at 3, 5, and 12 months of age...
- Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birthKenneth M Petersen
Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
Pediatr Infect Dis J 23:650-5. 2004..The duration of protection after hepatitis B vaccination of infants is unknown...
- Timeliness and completion rate of immunization among Nigerian children attending a clinic-based immunization serviceAyebo E Sadoh
Institute of Child Health, University of Benin, PMB 1154, Benin City, Edo State, Nigeria
J Health Popul Nutr 27:391-5. 2009..Only 227 (44.3%) children were fully immunized. Health education and mass mobilization of the community and health workers are recommended to improve the uptake of vaccines and to encourage timely receipt of vaccines...
- Short term evaluation of a rural immunization program in NigeriaO O Odusanya
Department of Community Health and Primary Care, Lagos State University College of Medicine, Ikeja, Nigeria
J Natl Med Assoc 95:175-9. 2003....
- Response to hepatitis B vaccine in preterm infants: four-dose scheduleA Ballesteros-Trujillo
Department of Neonatology, , Instituto Mexicano del Seguro Social, , Gto,
Am J Perinatol 18:379-85. 2001..Our schedule seems to be useful for PI infants and probably is no longer necessary to delay the vaccination, although this should be confirmed by further studies...
- Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trialLeon Heron
National Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Childrens Hospital, Westmead, Australia
Vaccine 25:2817-22. 2007..Both regimens were shown to be safe and well tolerated. Two doses of Engerix-B (20 microg HBsAg) could be considered as an alternative to standard three-dose Engerix-B (10 microg HBsAg) immunisation for adolescents aged 11-15 years...
- Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate contentKhin Hla Hla
Pediatric Unit No 2, Military Hospital, Dagon Township, Yangon, Myanmar
Pediatr Infect Dis J 25:706-12. 2006..5 microg of polyribosylribitol phosphate (PRP) conjugated to tetanus toxoid (trials Hib-052/064)...
- Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infantsS B Bavdekar
Seth G S Medial College and K E M Hospital, Mumbai, India
Indian Pediatr 44:505-10. 2007..To evaluate the immunogenicity of the Hepatitis B and Haemophilus influenzae type b components and the overall safety and reactogenicity of the DTPw-HBV/Hib vaccine when given as primary vaccination to Indian infants...
- The use of combination vaccines has improved timeliness of vaccination in childrenHelen Kalies
Department of Pediatric Epidemiology, Institute for Social Pediatrics and Adolescent Medicine of Ludwig Maximilians University, Munich, Germany
Pediatr Infect Dis J 25:507-12. 2006..We examined whether the use of combination vaccines has improved the timing of these vaccinations...
- Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strainPaul M Mendelman
MedImmune Vaccines, Mountain View, CA, USA
Pediatr Infect Dis J 23:1053-5. 2004..Results indicated that the live vaccine induced higher antibody responses than the inactivated vaccine against the A/Panama and A/Fujian-like viruses...
- Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccinesRobin E Huebner
Respiratory and Meningeal Pathogens Research Unit of the Medical Research Council, National Health Laboratory Service and the University of the Witwatersrand, Johannesburg, South Africa
Vaccine 23:802-6. 2004..Our data suggest that doses of these vaccines of > or =1.25 microg may be sufficient to stimulate an immune response that offers both short and longer term protection from invasive Hib disease...
- A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin AmericaMiguel Tregnaghi
Centro de Desarrollo de Proyectos Avanzados, Cordoba, Argentina
Rev Panam Salud Publica 19:179-88. 2006....
- Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity countryBernard Duval
Institut National de Sante Publique du Quebec, Quebec, Canada
Pediatr Infect Dis J 24:213-8. 2005..The long term effect of the booster dose in teenagers is unknown. We evaluated the immunogenicity of 2 pediatric hepatitis vaccines after primary vaccination and after a booster dose...
- Sex differential effects of routine immunizations and childhood survival in rural MalawiPeter Aaby
Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark
Pediatr Infect Dis J 25:721-7. 2006..Recent studies from West Africa suggest that routine vaccinations may have sex differential nontargeted effects. To answer whether these patterns are found elsewhere, we reanalyzed data about vaccinations and mortality in a Malawian cohort...
- Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccineFélix Omeñaca
Department of Neonatology, La Paz Hospital, Madrid, Spain
Pediatrics 119:e179-85. 2007....
- Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)Umesh D Parashar
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Rd, NE MS A 34, Atlanta, GA 30333, USA
MMWR Recomm Rep 55:1-13. 2006..Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine...
- Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001Fangjun Zhou
National Immunization Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA
Arch Pediatr Adolesc Med 159:1136-44. 2005To evaluate the economic impact of the routine US childhood immunization schedule: diphtheria and tetanus toxoids and acellular pertussis; tetanus and diphtheria toxoids; Haemophilus influenzae type b conjugate; inactivated poliovirus; ..
- Timeliness of childhood immunisation in AustraliaBrynley P Hull
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead and the University of Sydney, NSW, Australia
Vaccine 24:4403-8. 2006....
- Assessing immunization data quality from routine reports in MozambiqueJoão C Mavimbe
Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
BMC Public Health 5:108. 2005..The present article, discusses the practices on record keeping, reporting and the support mechanism to ensure data quality in Mozambique...
- Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsAmorsolo L Suguitan
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
PLoS Med 3:e360. 2006....
- Immunization coverage and its determinants in children aged 12-23 months in Gansu, ChinaFu Qiang Cui
Chinese Center for Disease Control and Prevention, P O Box 100050, Beijing, China
Vaccine 25:664-71. 2007..Improved immunization coverage could be achieved by improving access and delivery to poor and remote areas and by awarding incentives to providers at primary care level...
- Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaElissa M Malkin
Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5640 Fishers Lane, Twinbrook 1, Room 1123, Rockville, MD 20852, USA
Vaccine 23:3131-8. 2005..Pvs25H generates transmission blocking immunity in humans against P. vivax demonstrating the potential of this antigen as a component of a transmission blocking vaccine...
- Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of lifeMárcia Soares Freitas da Motta
Department of Pediatrics, School of Medicine of Ribeirao Preto, University of Sao Paulo, Av dos Bandeirantes no 3900, Ribeirao Preto, Sao Paulo, Brazil
Vaccine 20:1557-62. 2002..Currently accepted recommendations for post exposure perinatal prophylaxis may be inadequate to protect preterm infants...
- Hepatitis B vaccination in children with juvenile idiopathic arthritisO Kasapcopur
Department of Pediatrics, Cerrahpaa Medical Faculty, Istanbul University, Istanbul, Turkey
Ann Rheum Dis 63:1128-30. 2004..To evaluate the responsiveness of children with juvenile idiopathic arthritis (JIA) to hepatitis B vaccination and to determine the most useful vaccination schedule...
- Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationIain Stephenson
Infectious Diseases Unit, Leicester Royal Infirmary, LE1 5WW, Leicester, UK
Vaccine 21:1687-93. 2003..001). MF59 significantly increased GMTs of antibody when compared to non-adjuvanted vaccine (P<0.001)...
- Delayed immunisation and risk of pertussis in infants: unmatched case-control studyCameron C Grant
Department of Paediatrics, Faculty of Medicine and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
BMJ 326:852-3. 2003
- Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocolsN Linder
Dept of Neonatology, Schneider Children s Medical Center of Israel, Petah Tiqva
Infection 30:136-9. 2002..Two three-dose protocols were compared: vaccination beginning within 24 h of birth to initial vaccination delayed until a weight of 2,000 g was reached...
- The need for surveillance of delay in age-appropriate immunizationKevin J Dombkowski
Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor 48109 0456, USA
Am J Prev Med 23:36-42. 2002..Our study was conducted in 2000-2001 using the most current National Health Interview Survey (NHIS) public use files available...
- The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizationsCARLOS GRIJALVA; Fiscal Year: 2007..S. infant immunization schedule. Post-licensure surveillance has shown dramatic reductions in rates of invasive disease in vaccinated ..
- BioThrax Schedule Optimization for Post-Exposure Prophylaxis of AnthraxRobert Hopkins; Fiscal Year: 2006..This phase 3b clinical trial, Safety, Immunogenicity, and Immunization Schedule Study of Post-Exposure Prophylaxis for BioThrax(r) in a Population of Healthy Adults, will evaluate the ..
- A Randomized Trial of Vaccine Adherence in Young IDUPaula Lum; Fiscal Year: 2006..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
- Generation of antibodies by genetic immunizationHans Herweijer; Fiscal Year: 2002..studies, we will further optimize genetic immunization methods by including cytokine genes, refining the immunization schedule, and testing different expression vectors and mouse strains...
- Therapeutic Immunization in HumansJulianna Lisziewicz; Fiscal Year: 2003..The study is aimed to determine whether a one immunization schedule could replace and improve the two consecutive immunization schedule originally administered in the monkey ..
- Predictors of Cancer Screening in Diverse PracticesRichard Zimmerman; Fiscal Year: 2004..Without understanding the barriers to prevention from multiple vantage points, the rates of preventive services are unlikely to reach 2010 goals and needless cancer deaths will occur. ..
- DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATIONRichard Zimmerman; Fiscal Year: 2001..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
- The Immunogenetics of Measles ImmunityGregory A Poland; Fiscal Year: 2010..Globally, measles kills over 500,000 children annually, and small outbreaks continue to occur in the U.S. ..
- IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSEGregory Poland; Fiscal Year: 2005....
- The Immunogenetics of Measles ImmunityGregory Poland; Fiscal Year: 2006..abstract_text> ..
- IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSEGregory A Poland; Fiscal Year: 2010..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
- The Immunogenetics of Measles ImmunityGregory Poland; Fiscal Year: 2009..Globally, measles kills over 500,000 children annually, and small outbreaks continue to occur in the U.S. ..
- IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSEGregory Poland; Fiscal Year: 2007..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
- NATURE OF MEASLES IMMUNITY IN TWO POPULATIONSGregory Poland; Fiscal Year: 2001....
- MEASLES IMMUNITY IN TWO POPULATIONSGregory Poland; Fiscal Year: 1993..These data are important in formulating national policy to eliminate measles...
- ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATIONPaul Offit; Fiscal Year: 2005..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
- Optimal assessment of HAART adherence in routine clinical careHeidi M Crane; Fiscal Year: 2010..Optimally and routinely assessing adherence in clinical settings is an important step toward maximizing the potential benefit of antiretroviral therapy for all patients. ..
- An HB Vaccine Model For HIV Vaccine Trials in Drug UsersLu Yu Hwang; Fiscal Year: 2007..abstract_text> ..
- PROTECTION FROM VIRAL GASTROENTERITIS BY INTESTINAL CTLSPaul Offit; Fiscal Year: 1993..Adaptation of murine rotaviruses to growth in tissue culture allows for an accurate determination of the virus dose used for in vitro and in vivo studies...
- Brucella, Aging and Role of IL-17 in Host DefenseKevin High; Fiscal Year: 2005..The data generated in this proposal will form the foundation of future R01 proposals aimed at enhancing immunity vs. intracellular pathogens in our aging population. ..
- TRAINING IN PEDIATRIC INFECTIOUS DISEASEAnne Gershon; Fiscal Year: 2007..The renewal of this training grant will enable us to continue a training program that has so far been highly successful at this University during the past 5 years. ..
- Functional Senescence of Innate Immunity and PneumoniaKevin High; Fiscal Year: 2003..These data are essential to design meaningful studies using the case-control method, the most effective means of studying the link between immune senescence and infection risk. ..
- CHEMOIMMUNOTHERAPY FOR BREAST CANCER TREATMENTLeisha Emens; Fiscal Year: 2006..abstract_text> ..
- PEDIATRIC AIDS CLINICAL TRIALS UNITColeen Cunningham; Fiscal Year: 2005..abstract_text> ..
- PEDIATRICS AIDS CLINICAL TRIALS GROUPAnne Gershon; Fiscal Year: 2006..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
- Molecular Epidemiology, Virulence, and Genomic Characterization of UreaplasmasKen Waites; Fiscal Year: 2007....
- VZV Receptors and Infective MechanismsAnne Gershon; Fiscal Year: 2007..It may also make it possible to develop a safer and more efficacious vaccine. ..
- ENHANCEMENT OF IMMUNOGENICITY BY MICROENCAPSULATIONPaul Offit; Fiscal Year: 1999..alter the fine antigenic specificities of virus-specific neutralizing antibodies or CTLs? 4) Does oral inoculation of mice with microencapsulated virus or viral proteins enhance the capacity of immunization to protect against challenge? ..
- Lipodystrophy among HIV-infected patientsHeidi Crane; Fiscal Year: 2007..abstract_text> ..
- Dynamic Modeling of the HCV Epidemic in IDUJudith Hahn; Fiscal Year: 2007..Public Health Relevance: This training and research will equip Dr. Hahn with the tools to conduct modeling studies based on solid epidemiologic data to guide the planning of effective interventions to reduce the HCV epidemic in IDU. ..
- Exploratory Center for Vaccinology Research (RMI)Walter Orenstein; Fiscal Year: 2007..abstract_text> ..
- VACCINE EFFICACY IN CHILDREN WITH SICKLE CELL DISEASEThomas Adamkiewicz; Fiscal Year: 2006..abstract_text> ..
- Exploratory Center for Vaccinology Research (RMI)James Hughes; Fiscal Year: 2006....
- Analyzing Vaccine Programs/Policies in Western EuropeGary Freed; Fiscal Year: 2004..abstract_text> ..